Discovery offers hope for reducing immune-related heart risks in cancer patients

https://www.news-medical.net/news/20260220/Discovery-offers-hope-for-reducing-immune-related-heart-risks-in-cancer-patients.aspx For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar brand names.